secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcturus Therapeutics Holdings Inc. (ARCT)
CIK:        0001768224
Form:       8-K
Filed at:   2026-06-05T21:20:32+00:00
Accession:  0001193805-26-000770
Event type: other
Sentiment:  neutral
Materiality: 0.00
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Arcturus Therapeutics shareholders elect all eight director nominees, approve say-on-pay, and ratify Deloitte as auditor
--------------------------------------------------------------------------------

- All eight director nominees (Farrell, Payne, Barlow, Holmes, Marquet, Marantz, Markels, Slaoui) elected with over 15M votes each.
- Non-binding advisory say-on-pay approved: 15.25M for, 327,647 against, 176,375 abstain.
- Ratification of Deloitte as independent auditor for 2026 approved: 21.38M for, 46,823 against, 10,349 abstain.
- Quorum of 21.44M shares present out of 28.42M shares entitled to vote.
- All proposals passed with no significant opposition; no other business transacted.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1768224/000119380526000770/0001193805-26-000770-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1768224/000119380526000770/e665552_8k-arct.htm
  HTML page:      https://secwatch.observer/filing/0001193805-26-000770

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer